Barely Significant
← all excerpts

Combination therapy of targeting CD20 antibody and immune checkpoint inhibitor may be a breakthrough in the treatment of B-cell lymphoma.

Heliyon · 2024 · PMC11315150 · PMID 39130438

1
hedged sentence
closest p
boldest claim

The sentences

an increasing trendno p-value reported
2 , shows an increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.